Burst Diagnostics
PrivateLast Round
Grant
Oct 29, 2025
Total Funding Raised
$830,856
Company Overview
Burst Diagnostics operates in Healthcare & Life Sciences and is based in Fort Collins, Colorado. Its latest recorded funding round was a Grant round in October 2025.
Burst Diagnostics is a medical devices and equipment company that develops rapid, paper-based, point-of-care diagnostic test platforms designed to provide quantitative, lab-quality results.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Burst Diagnostics Comparables
Compare Burst Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Chronus Health | 88% | |
| FluxErgy | 82% | |
| Genspeed Biotech GmbH | 80% |
For institutional investors. Book with your work email.
Burst Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 29, 2025 | ||||
| Seed Round | Jan 3, 2024 | ||||
| Grant | Sep 19, 2023 | ||||
| Grant | May 18, 2023 | ||||
| Seed | Mar 2, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Burst Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Advanced Industries Accelerator Program | Grant |
| National Institutes of Health (NIH) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 29, 2025
$301K grant received from the National Institutes of Health.
- Sep 19, 2023
$280K grant received from the National Institutes of Health.
For institutional investors. Book with your work email.
Burst Diagnostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Burst Diagnostics's valuation, stock price, and market status.
Is Burst Diagnostics a public or private company?
Burst Diagnostics is a private company.
What is the current stock price of Burst Diagnostics?
Burst Diagnostics is a private company, so its shares have no public market price. Caplight tracks Burst Diagnostics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Burst Diagnostics worth (valuation)?
Valuation information for Burst Diagnostics is not publicly available.
Can I buy Burst Diagnostics stock?
Burst Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Burst Diagnostics's last funding round?
Burst Diagnostics's most recent funding round was Grant on October 29, 2025.
Who are the main investors in Burst Diagnostics?
Key investors in Burst Diagnostics include Advanced Industries Accelerator Program, National Institutes of Health (NIH).
Will Burst Diagnostics IPO soon?
No public IPO plans have been announced for Burst Diagnostics.
How can I track Burst Diagnostics secondary market activity?
Caplight tracks bids, offers, and trades in Burst Diagnostics's shares on secondary markets.